What cGMPnow does

cGMPnow is a Boulder, Colorado-based private consulting firm that delivers turn-key GxP systems and services to pharmaceutical, biopharmaceutical, and advanced therapeutic manufacturers building or qualifying GMP production facilities. The company's portfolio is organized into three integrated service pillars: GxP System Integration and Delivery (specification development, facility and MEP design, equipment procurement, Part 11 compliant computerized systems, and full commissioning, qualification and validation); GMP Real Estate Services (site selection, design/build and leaseback, delivered in partnership with Vitrian); and GMP Compliance Services (Annex 1 audits, contamination control strategy, QA staff augmentation, periodic requalifications, investigations and CAPAs). The firm is sharply specialized in next-generation modalities — autologous and allogeneic cell therapies (CAR-T, NK, iPSC, IO, MSCs), viral vector platforms (AAV, RV, LV, HAV, OV), pDNA, mRNA, LNP, and traditional biologics and small molecules.

The company's core technical differentiator is an integrated, owner-focused delivery methodology in which dedicated, full-time project teams of industry experts carry a facility from inception through CQV and turnover, eliminating the standard industry silos between A&E/GC design, GxP equipment, computerized systems, and CQV documentation. Underlying technology assets include Part 11 compliant hardware and software, cGxP specification frameworks (PRS, URS, FRS, DDS), and facility design capabilities calibrated to FDA and EMA ATMP standards. Leadership — CEO Jeff Gilmore, CBO Dan Swanson, and COO Grayson Heller — collectively bring over $1B in prior GxP project experience and trace a lineage through Vista Engineering Group and prior tenures at Amgen, AstraZeneca, Novartis, Roche, and CH2M Hill.

cGMPnow operates a project-based professional services and equipment resale model, with multi-year contracts, quote-based pricing, and additional recurring revenue potential from ongoing compliance engagements and a managed real estate offering via Vitrian. Distribution is purely direct enterprise field sales, supported by regional delivery presence in Boulder, San Diego, and Indianapolis. Named customers include Amgen, AstraZeneca, Novartis, AveXis, and STAQ Pharma. The company does not disclose revenue, funding, or headcount, and has no disclosed AI/ML capabilities; its competitive position rests on senior GxP talent, regulatory expertise, and an integrated delivery model.

Name

cGMPnow

Legal name

cGMPnow

Website

https://cgmpnow.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

cGMPnow is a Boulder, Colorado-based GxP consulting firm that delivers turn-key GMP facility design, equipment, computerized systems, validation, compliance, and real estate services to pharmaceutical and advanced therapy manufacturers building cell, gene, viral vector, and mRNA production facilities.

Ownership category

akta.pro rank

Product category

Pharmaceutical GMP Engineering & Compliance Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

GMP Quality, Validation & Regulatory Support (GMP/CSV/Qualification) (HLAGAGAL)

akta.pro secondary industries

GMP Manufacturing Support Services (QA/QMS, validation, documentation) (HLAAAKAH), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)

Keywords

• GMP facility engineering
• Pharmaceutical compliance consulting
• GxP systems integration
• Cell therapy manufacturing
• Biopharmaceutical project management

Headquarters

HQ city

Boulder

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. GxP System Integration Services: Professional services including GxP specification development, GMP facility design, equipment procurement, commissioning & qualification, and validation services delivered through project-based engagements with dedicated expert resources
2. GMP Equipment Sales: Supply of GxP Manufacturing & QC Laboratory Equipment including bioreactors, fermentors, mixers, chromatography systems, TFF, isolators, and vial/bag fillers as part of turn-key project delivery
3. GMP Compliance Services: Ongoing compliance services including quality systems support, Annex 1 compliance audits, contamination control strategy development, GMP training, QA staff augmentation, periodic requalifications, and deviation/CAPA investigations
4. GMP Real Estate Services: Strategic real estate partnership providing site selection, design/build, and leaseback services for GMP manufacturing facilities through partnership with Vitrian

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

cGMPnow provides turn-key GMP systems and services for next generation therapeutic product manufacturing, including GxP specification development, GMP ATMP facility conceptual and detailed design, key manufacturing and QC laboratory equipment procurement, Part 11 compliant GxP computerized systems, and full equipment, facility, and computerized system commissioning, qualification, and validation. The portfolio is rounded out by GMP real estate services (site selection, design/build, leaseback via the Vitrian partnership) and GMP compliance services (Annex 1 audits, contamination control, QA staff augmentation, GMP training, requalifications, and CAPA investigations). All work is delivered by dedicated, full-time expert project teams from inception through CQV and turnover.

Product overview

cGMPnow offers a unified portfolio of turn-key GMP systems and services for next generation therapeutic product manufacturing. The portfolio consists of three integrated service pillars: GxP System Integration & Delivery Services (specification development, facility design, equipment procurement, computerized systems, and commissioning/qualification/validation), GMP Real Estate Services (site selection, design/build, and leaseback in partnership with Vitrian), and GMP Compliance Services (quality systems, audits, training, and regulatory support). The company also provides specialized manufacturing solutions for advanced therapeutics including cell therapy, viral vectors, mRNA, and biologics. All services are delivered by dedicated project teams of industry experts committed full-time to project delivery from inception through CQV and turnover.

Differentiator

Problem solved

Functional benefit

Products and services

• GxP System Integration & Delivery Services

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• VitriancoreStrategic or Co-development PartnerVitrian is cGMPnow's Real Estate Strategic Partner for GMP Manufacturing development. Through this partnership, cGMPnow provides comprehensive end-to-end GMP real estate support including up-front site selection and due diligence, full GMP facility design/build with subsequent leaseback options, and GMP manufacturing facility make-vs-buy assessments. This strategic relationship enables cGMPnow to offer true end-to-end solutions for clients seeking to accelerate therapeutic product manufacturing.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• PM Group: PM Group is an international project management, engineering, and construction firm specializing in life sciences and food manufacturing facilities. It directly competes on integrated facility delivery for pharma and biopharma clients.
• IPS (Integrated Project Services): IPS is a life sciences-focused engineering and construction firm providing architecture, CQV, and validation services. It is a comparable integrated GxP delivery competitor within the same pharma/biotech customer base.
• Eagle Pharma Engineering: Eagle Pharmaceutical Engineering is a specialized consulting firm providing GMP facility design, validation, and compliance services for pharma and biopharma manufacturers. It is comparable in size and service scope to cGMPnow.
• Commissioning Agents Inc (CAI): CAI is a global consulting firm specializing in commissioning, qualification, validation, and quality services for life sciences manufacturers. It is a direct peer in the CQV and GMP compliance services layer of cGMPnow's offering.
• CRB Group: CRB is a leading global engineering, architecture, and construction firm focused on life sciences and advanced technology facilities. It directly competes with cGMPnow in GMP facility design, CQV, and integrated delivery for pharma and biopharma clients.

Broad incumbents

• Arcadis (formerly IBI): Arcadis is a global design and consultancy firm with a life sciences practice delivering facility design, CQV, and compliance services for pharma and biotech. It operates as a broader infrastructure consultancy with a focused life sciences vertical.
• Exyte: Exyte (formerly M+W Group) is a global high-tech facility design-build firm with deep biopharma expertise. It competes with cGMPnow on GMP facility builds but operates at a much larger scale with international delivery capability.
• Wood PLC: Wood is a global consulting and engineering firm with a life sciences/pharma facility design and CQV practice. It competes on large-scale enterprise pharma projects but is not a specialist in cell and gene therapy builds.
• AECOM: AECOM is a global infrastructure consulting firm with a life sciences and pharma facility design practice. It competes for large capital projects but serves a broader industry base than cGMPnow's ATMP focus.
• Jacobs Engineering: Jacobs is a large global professional services firm with a life sciences practice covering pharma facility design, CQV, and compliance. It competes on the largest enterprise engagements where cGMPnow could be a sub-contractor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about cGMPnow